113 related articles for article (PubMed ID: 25307441)
1. [Treatment of chronic hepatitis C in drug users: ethic, successful and useful].
Remy AJ; Wenger H; Bouchkira H
Presse Med; 2014 Dec; 43(12 Pt 1):1314-6. PubMed ID: 25307441
[No Abstract] [Full Text] [Related]
2. Hazardous alcohol consumption and other barriers to antiviral treatment among hepatitis C positive people receiving opioid maintenance treatment.
Watson B; Conigrave KM; Wallace C; Whitfield JB; Wurst F; Haber PS
Drug Alcohol Rev; 2007 May; 26(3):231-9. PubMed ID: 17454012
[TBL] [Abstract][Full Text] [Related]
3. Methadone and buprenorphine maintenance therapies for patients with hepatitis C virus infected after intravenous drug use.
Verrando R; Robaeys G; Matheï C; Buntinx F
Acta Gastroenterol Belg; 2005; 68(1):81-5. PubMed ID: 15832591
[TBL] [Abstract][Full Text] [Related]
4. Treatment for hepatitis C virus in injection drug users on opioid replacement therapy: a prospective multicentre study.
Belfiori B; Chiodera A; Ciliegi P; Tosti A; Baldelli F; Stagni G; Francisci D
Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):731-2. PubMed ID: 17625449
[No Abstract] [Full Text] [Related]
5. [Hepatitis C and drug use: epidemiology, screening, natural history and treatment].
Lucidarme D
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B112-20. PubMed ID: 12180278
[No Abstract] [Full Text] [Related]
6. Antiviral treatment for chronic hepatitis C in illicit drug users: a systematic review.
Zanini B; Lanzini A
Antivir Ther; 2009; 14(4):467-79. PubMed ID: 19578232
[TBL] [Abstract][Full Text] [Related]
7. High rates of sustained virological response in hepatitis C virus-infected injection drug users receiving directly observed therapy with peginterferon alpha-2a (40KD) (PEGASYS) and once-daily ribavirin.
Waizmann M; Ackermann G
J Subst Abuse Treat; 2010 Jun; 38(4):338-45. PubMed ID: 20362408
[TBL] [Abstract][Full Text] [Related]
8. Relapse to opioid use after treatment of chronic hepatitis C with pegylated interferon and ribavirin.
Matthews AM; Fireman M; Zucker B; Sobel M; Hauser P
Am J Psychiatry; 2006 Aug; 163(8):1342-7; quiz 1479. PubMed ID: 16877644
[No Abstract] [Full Text] [Related]
9. High prevalence of late relapse and reinfection in prisoners treated for chronic hepatitis C.
Bate JP; Colman AJ; Frost PJ; Shaw DR; Harley HA
J Gastroenterol Hepatol; 2010 Jul; 25(7):1276-80. PubMed ID: 20594255
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C in injection drug users: It is time to treat.
Grassi A; Ballardini G
World J Gastroenterol; 2017 May; 23(20):3569-3571. PubMed ID: 28611509
[TBL] [Abstract][Full Text] [Related]
11. Peginterferon plus Ribavirin for chronic hepatitis C in opiate addicts on methadone/buprenorphine maintenance therapy.
Belfiori B; Ciliegi P; Chiodera A; Bacosi D; Tosti A; Baldelli F; Francisci D
Dig Liver Dis; 2009 Apr; 41(4):303-7. PubMed ID: 18938116
[TBL] [Abstract][Full Text] [Related]
12. [Prevention and treatment of hepatitis C in illicit drug users].
Sakoman S
Acta Med Croatica; 2009 Dec; 63(5):437-42. PubMed ID: 20198904
[TBL] [Abstract][Full Text] [Related]
13. Prisons, prisoners, and hepatitis C.
Ferguson L; Batey R
J Gastroenterol Hepatol; 2010 Jul; 25(7):1184-6. PubMed ID: 20594243
[No Abstract] [Full Text] [Related]
14. [Striving for individual therapy].
MMW Fortschr Med; 2013 Jun; 155 Suppl 1():40-1. PubMed ID: 23961654
[No Abstract] [Full Text] [Related]
15. [Treatment of hepatitis C in intravenous drug users].
Filoche B
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B252-6. PubMed ID: 12180298
[No Abstract] [Full Text] [Related]
16. Barriers to antiviral treatment in hepatitis C infected intravenous drug users.
Gazdag G; Horvath G; Szabo O; Ungvari GS
Neuropsychopharmacol Hung; 2010 Dec; 12(4):459-62. PubMed ID: 21220790
[TBL] [Abstract][Full Text] [Related]
17. Treatment of chronic hepatitis C in active drug users.
Davis GL; Rodrigue JR
N Engl J Med; 2001 Jul; 345(3):215-7. PubMed ID: 11463020
[No Abstract] [Full Text] [Related]
18. [Burden of disease and level of patient's medical care in substitution treatment for opiates].
Müller MC; Pichler M; Martin G; Plörer D; Winter C; Pogarell O; Bogner JR
Med Klin (Munich); 2009 Dec; 104(12):913-7. PubMed ID: 20039157
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C treatment of opioid dependants receiving maintenance treatment: results of a Norwegian pilot study.
Krook AL; Stokka D; Heger B; Nygaard E
Eur Addict Res; 2007; 13(4):216-21. PubMed ID: 17851243
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C management by addiction medicine physicians: results from a national survey.
Litwin AH; Kunins HV; Berg KM; Federman AD; Heavner KK; Gourevitch MN; Arnsten JH
J Subst Abuse Treat; 2007 Jul; 33(1):99-105. PubMed ID: 17379472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
